Coherent Biopharma

Coherent Biopharma

同宜医药

Coherent Biopharma

Biotech/Healthcare

Tongyi Pharma has developed a proprietary platform for multi-target ligand-drug conjugates. By leveraging the natural binding between cancer-cell surface receptors and ligands together with drug-conjugation technology, the company is developing ligand-drug conjugates for lung, gastric, liver, and…

Latest round: Series B Extension (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-05-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.